TILT Biotherapeutics Ltd is the leading company globally working in the area of enabling tumor T-cell therapy and checkpoint inhibitors with oncolytic viruses. TILT Biotherapeutics is developing a new treatment for cancer using oncolytic immunotherapy. Advanced solid tumors are difficult to treat with limited treatment options available. However, preclinical data on TILT® technology, alone and in combination with other immuno...
TILT Biotherapeutics Ltd is the leading company globally working in the area of enabling tumor T-cell therapy and checkpoint inhibitors with oncolytic viruses. TILT Biotherapeutics is developing a new treatment for cancer using oncolytic immunotherapy. Advanced solid tumors are difficult to treat with limited treatment options available. However, preclinical data on TILT® technology, alone and in combination with other immunotherapy agents (such as T-cells and checkpoint inhibitors) have demonstrated 100% cure rates.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.